Rafael Pharmaceuticals

Rafael resets after phase 3 flop, parting ways with 5 execs and reinstating telecom tycoon as CEO
Fierce Biotech
Tue, 11/23/21 - 09:47 am
Rafael Pharmaceuticals
devimistat
clinical trials
pancreatic cancer
AML
reorganization